|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
HALE DAVID F 6707 DEMOCRACY BOULEVARD, SUITE 505 BETHESDA, MD 20817 |
X |
/s/ Brian F. Leaf, attorney-in-fact | 09/25/2007 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The shares reported on this Form 4 were issued under the issuer's 2003 Amended and Restated Equity Incentive Award Plan pursuant to the reporting person's election to receive a portion of his cash compensation for director service for the quarterly period ended June 30, 2007 in shares of common stock. The reporting person earned $4,000 in fees for such period pursuant to the issuer's director compensation policy for serving as a director. Of this amount, $2,667 was paid in cash, and the remaining $1,333 was paid in shares valued at the closing price of the issuer's common stock on September 19, 2007. |
(2) | By Michael T. Hale Trust dated December 26, 1991 for the benefit of Shane Hale, Tara Hale, Erin Hale and David Garrett Hale. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose. |
(3) | By Hale Family Trust dated February 10, 1986. |
(4) | These securities are held by Hale BioPharma Ventures, LLC, a limited liability company controlled by the reporting person. |